As of 2022, the global anti-obesity drugs market was estimated to be worth US$ 1.7 billion, and is expected to grow at a substantial CAGR of over 17%.
Market Scope and Report Overview
In a comprehensive market analysis by RationalStat, the world anti-obesity drug market is analyzed on the foundation of the market segmentation which include the type of drug, distribution channel and geographic regions (incl. North America, Latin America, Western Europe, Eastern Europe, Middle East & Africa, and Asia Pacific). The report also gives the market size of both regional and global markets for the period from 2019-2022, and for the forecast period from 2019-2028.
Market intelligence for the global anti-obesity drugs market covers market sizes on the basis of market value (US$/EUR Million) and volume ('000 units/tons/liters) by various products/services/equipment, demand assessment across the key regions, customer sentiments, price points, cost structures, margin analysis across the value chain, financial assessments, historical and forecast data, key developments across the industry, import-export data, trade overview, components market by leading companies, etc.
Additionally, the long-term sector and the 10-year outlook for products and services and its impact on the market for anti-obesity medicines. It also provides information on the current status of the industry Production levels, Capacity Utilization, Tech Quotient, and more. Important information includes manufacturing capacity for each country, installed base volume, imports market size, the number of major players and market size dynamic, market information and insights, among others.
Period Covered includes data for 2019-2028, along with the estimated demand for each year
The report on anti-obesity drugs market examines the market on the context of global economic conditions, regional geopolitics, trade duty scenarios, import-export scenario, market trends, organic and inorganic strategies, mergers & acquisitions, new product launches, policies of the government, new capacity expansion, technological advances, R&D investments, and new market entry rates, rate of replacement, rates of penetration, capacity of installed base/fleets, global and regional production capacities, and many more.
RationalStat provides market analysis and consultation studies on the basis of a solid desk/secondary research, backed by an internal data repository. Additionally, the research draws on data that is based on real-time information gathered through interviews conducted by primary sources. Market estimates and insight are built upon the primary data (covering over 240 organizations) as well as secondary research using international benchmarking.
The global anti-obesity drugs market report report also includes supply chain and value chain analysis, which provides comprehensive details on the value chain's margins and the importance of various stakeholders in the value chain. Market dynamics provided in the market study include market drivers, restraints/challenges, trends, and their impact on the market throughout the analysis period.
In the competition analysis section, the global anti-obesity drugs market offers a thorough competition benchmarking analysis based on the market share of the most prominent manufacturers/brands/suppliers, an overview of the market structure, including comprehensive company profiles of over 25 companies, including their financials, offerings of products and services major changes as well as business models. This allows customers and report purchasers to take robust, precise and swift decision-making.
Find out more information about this report Contact us for a a Sample and the Scope of the Study
Macroeconomic Scenario and the Impact of COVID-19 on Regional Economic Sentiment
In the most recent RationalStat analysis, it is clear that the geopolitical tensions and inflation are among the most cited threats to economic growth, while worries about the risk of instability across all the energy industry are commonplace in Europe and other regions of the globe. One of the threats to development of the economy in the top regions, such as Asia Pacific, Europe, North America, the Middle East and Africa and other emerging regions are the rising cost of energy, inflation and supply chain disruptions, geopolitical instability, the shortage of labor and rising interest rates and the COVID-19 pandemic.
The global economy faced severe headwinds throughout 2019-2021 when some countries saw slow growth, whereas others struggled with slowdowns in the economy. The COVID-19 virus has caused excessive pressure on a wide range of industries around the globe and created a severe financial crisis across the US, India, Italy, the UK, Germany, Japan, South Korea and many other countries. Besides, the exit of the UK from the European Union earlier in 2020 and the Russo-Ukraine war in 2022 exacerbated the ever-heightened global uncertainty.
Furthermore, the global economy slowed in 2022 to 3.3%, lower than the forecast for the final quarter of 2021. The reason for this was that it was mostly weighed down by the Russian war in Ukraine and the cost of living crisis in several nations. However, growth in the economy over the forecast timeframe is anticipated. It is predicted that growth will remain at a slower rate between 2023 and 2024, which will be 2.6% and 2.9% respectively.
Competition Analysis and Market Structure
Some of the prominent players that contribute significantly to the anti-obesity drugs market growth include Novo Nordisk A/S, GlaxoSmithKline plc, VIVUS LLC, Currax Pharmaceuticals LLC, Hoffamann-La Roche Ltd., Pfizer Inc., Sandoz International GmbH, Boehringer Ingelheim International GmbH, Arena Pharmaceuticals Inc., Takeda Pharmaceuticals Company Ltd., Merck & Co. Inc., Eisai Co. Ltd., Novo Nordisk A/S and among others.
RationalStat has segmented the global anti-obesity drugs market based on type, distribution channel, and region
- Global Anti-Obesity Drugs Market Value (US$ Million), Volume (‘000 units/tons), and Market Share (2019-2028) Analysis by Type
- Prescription Drugs
- OTC Drugs
- Global Anti-Obesity Drugs Market Value (US$ Million), Volume (‘000 units/tons), and Market Share (2019-2028) Analysis by Distribution Channel
- Hospital Pharmacy
- Retail and Online Pharmacy
- Global Anti-Obesity Drugs Market Value (US$ Million), Volume (‘000 units/tons), and Market Share (2019-2028) Analysis by Region
- North America Anti-Obesity DrugsMarket
- Latin America Anti-Obesity DrugsMarket
- Rest of Latin America
- Western Europe Anti-Obesity DrugsMarket
- Rest of Western Europe
- Eastern Europe Anti-Obesity DrugsMarket
- Other CIS Countries
- Rest of Eastern Europe
- Asia PacificAnti-Obesity Drugs Market
- South Korea
- Rest of ASEAN
- Rest of Asia Pacific
- Middle East & Africa Anti-Obesity DrugsMarket
- Saudi Arabia (KSA)
- United Arab Emirates (UAE)
- Rest of the GCC
- South Africa
- Rest of the Middle East & Africa
- North America Anti-Obesity DrugsMarket
- Leading Companies and Market Players
- Novo Nordisk A/S
- GlaxoSmithKline plc
- VIVUS LLC
- Currax Pharmaceuticals LLC
- Hoffamann-La Roche Ltd.
- Pfizer Inc.
- Sandoz International GmbH
- Boehringer Ingelheim International GmbH
- Arena Pharmaceuticals Inc.
- Takeda Pharmaceuticals Company Ltd.
- Merck & Co. Inc.
- Eisai Co. Ltd.
- Novo Nordisk A/S
For more information about this report: https://store.rationalstat.com/store/global-anti-obesity-drugs-market/
Key Questions Answered in the Anti-Obesity Drugs Report:
- What will be the market value of the global anti-obesity drugsmarket by 2028?
- What is the market size of the global anti-obesity drugsmarket?
- What are the market drivers of the global anti-obesity drugsmarket?
- What are the key trends in the global anti-obesity drugsmarket?
- Which is the leading region in the global anti-obesity drugsmarket?
- What are the major companies operating in the global anti-obesity drugsmarket?
- What are the market shares by key segments in the global anti-obesity drugsmarket?
About RationalStat LLC
RationalStat is an end-to-end global market intelligence and consulting company that provides comprehensive market research reports, customized strategy, and consulting studies. The company has sales offices in India, Mexico, and the US to support global and diversified businesses. The company has over 80 consultants and industry experts, developing more than 850 market research and industry reports for its report store annually.
RationalStat has strategic partnerships with leading data analytics and consumer research companies to cater to the client’s needs. Additional services offered by the company include consumer research, country reports, risk reports, valuations and advisory, financial research, due diligence, procurement and supply chain research, data analytics, and analytical dashboards.
Kimberly Shaw, Content and Press Manager
Phone: +1 302 803 5429